Skip to main content
SpringerLink
Log in

V.A.6. Vitreous Surgery of Arterial and Venous Retinovascular Diseases

  • Chapter
  • First Online:
Vitreous

Abstract

Retinal vascular occlusions are traditionally considered major causes of ocular morbidity due to their drastic impact on central visual function. Modern ophthalmology has introduced an array of new therapeutic modalities that are being tested through clinical trials with promising results. Therapies such as anti-vascular endothelial growth factors, VEGF receptor binding agents, and steroid pharmacotherapy are rapidly evolving to replace traditional conservative treatment and laser therapy. While pharmacologic therapy will probably be the gold standard of practice in the near future, modern vitreoretinal surgery offers important treatment options that would complement pharmacotherapy. Surgical embolectomy for retinal arterial occlusions and radial optic neurotomy and sheathotomy for retinal vein occlusions are techniques that have long been regarded intimidating. Refined instrumentation and better vitrectomy viewing systems greatly reduce the surgical risk of these procedures and make them feasible for most vitreoretinal surgeons, thereby rendering them effective backup options in those patients in whom pharmacotherapy carries a guarded prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gass JDM. Obstructive retinal arterial diseases. In: Stereoscopic atlas of macular diseases. Diagnosis and treatment. 4th ed. St. Louis: Mosby; 1997. p. 444–66.

    Google Scholar 

  2. Hayreh SS, Jonas JB. Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion: an experimental study in rhesus monkeys. Am J Ophthalmol. 2000;129:786–95.

    Article  PubMed  CAS  Google Scholar 

  3. Duker JS, Brown GC. Recovery following acute obstruction of the retinal and choroidal circulations. A case history. Retina. 1988;8:257–60.

    Article  PubMed  CAS  Google Scholar 

  4. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125:509–20.

    Article  PubMed  CAS  Google Scholar 

  5. Schmidt D, Schumacher M, Wakhloo AK. Microcatheter urokinase infusion in central retinal artery occlusion. Am J Ophthalmol. 1992;113:429–34.

    Article  PubMed  CAS  Google Scholar 

  6. Beatty S, Au Fong KG. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol. 2000;84:914–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Noble J, Weizblit N, Baerlocher MO, Eng KT. Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol. 2008;92:588–93.

    Article  PubMed  CAS  Google Scholar 

  8. The EAGLE Study Group. Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology. 2010;117:1367–75.

    Article  Google Scholar 

  9. Peyman GA, Gremillion CM. Surgical removal of a branch retinal artery embolus: a case report. Int Ophthalmol. 1990;14:295–8.

    Article  PubMed  CAS  Google Scholar 

  10. Carvalho AR, Zapata M, Distefano L, Salas A, Macià C, Garcia-Arumi J. Histological findings in a pig model of experimental branch retinal artery occlusion. Poster presented at: ARVO 2011, 1–5 May, Florida.

    Google Scholar 

  11. Garcia-Arumi J, Martinez-Castillo V, Boixadera A, Fonollosa A, Corcostegui B. Surgical embolus removal in retinal artery occlusion. Br J Ophthalmol. 2006;90:1252–5.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  12. Garcia-Arumi J. Retinal vascular diseases: surgery, anti-VEGF, and steroid implants (unpublished lecture notes). Congress of the Ophthalmological Society of Valencia, Valencia, 2012.

    Google Scholar 

  13. Klein R, Klein BEK, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133–43.

    PubMed  CAS  PubMed Central  Google Scholar 

  14. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol. 1996;114:1243–7.

    Article  PubMed  CAS  Google Scholar 

  15. Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD, Rehmar AJ. Radial optic neurotomy for central retinal vein occlusion. A retrospective pilot study of 11 consecutive cases. Retina. 2001;21:408–15.

    Article  PubMed  CAS  Google Scholar 

  16. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981;79:371–422.

    PubMed  CAS  PubMed Central  Google Scholar 

  17. Spaide RF, Klancnik JM, Gross NE. Retinal choroidal collateral circulation after radial optic neurotomy correlated with the lessening of macular edema. Retina. 2004;24:356–9.

    Article  PubMed  Google Scholar 

  18. Garcia-Arumi J, Boixadera A, Martinez-Castillo V, Castillo R, Dou A, Corcostegui B. Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion. Arch Ophthalmol. 2003;121:1385–91.

    Article  Google Scholar 

  19. Fuller JF, Mason III JO, White MF, McGwin G, Emond TL, Feist RM. Retinochoroidal collateral veins protect against anterior segment neovascularization after central retinal vein occlusion. Arch Ophthalmol. 2003;121:332–6.

    Article  PubMed  Google Scholar 

  20. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE. Radial optic neurotomy for central retinal vein occlusion. 117 consecutive cases. Retina. 2006;26:297–305.

    Article  PubMed  Google Scholar 

  21. Garcia-Arumi J, Boixadera A, Martinez-Castillo V, Blasco H, Lavaque A, Corcostegui B. Radial optic neurotomy for management of hemicentral retinal vein occlusion. Arch Ophthalmol. 2006;124:690–5.

    Article  PubMed  Google Scholar 

  22. Garcia-Arumi J, Boixadera A, Martinez-Castillo V, Montolio M, Verdugo A, Corcostegui B. Radial optic neurotomy in central retinal vein occlusion: comparison of outcome in younger vs older patients. Am J Ophthalmol. 2007;143:134–40.

    Article  PubMed  Google Scholar 

  23. Hasselbach HC, Ruefer F, Feltgen N, Schneider U, Bopp S, Hansen LL, Hoerauf H, Bartz-Schmidt U, Roider J. Treatment of central retinal vein occlusion by radial optic neurotomy in 107 cases. Graefes Arch Clin Exp Ophthalmol. 2007;245:1145–56.

    Article  PubMed  CAS  Google Scholar 

  24. Binder S, Aggermann T, Brunner S. Long-term effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series. Graefes Arch Clin Exp Ophthalmol. 2007;245:1447–52.

    Article  PubMed  Google Scholar 

  25. The PACORES Study Group. Radial optic neurotomy for central retinal vein occlusion. Results of the Pan-American Collaborative Retina Study Group (PACORES). Retina. 2008;28:1044–52.

    Article  Google Scholar 

  26. The central vein occlusion study group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997;115:486–91.

    Google Scholar 

  27. The ROVO study group. A prospective, randomized, multicentral trial for surgical treatment of central retinal vein occlusion: results of the Radial Optic Neurotomy for Central Vein Occlusion (ROVO) study group. Graefe’s Arch Clin Exp Ophthalmol. 2012. doi:10.1007/s00417-012-2134-1.

  28. The SCORE Study Group. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care versus COrticosteroid for REtinal vein occlusion study report 10. Ophthalmology. 2011;118:345–52.

    Article  Google Scholar 

  29. McAllister IL, Gillies ME, Smithies LA, Rochtchina E, Harper CA, Daniell MD, Constable IJ, Mitchell P. The central retinal vein bypass study: a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion. Ophthalmology. 2010;117:954–65.

    Article  PubMed  Google Scholar 

  30. The CRUISE Study. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology. 2011;118:2041–9.

    Article  Google Scholar 

  31. The COPERNICUS Study. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol. 2013;155:429–37.

    Article  Google Scholar 

  32. Hayreh SS. Radial optic neurotomy for central retinal vein occlusion. Retina. 2002;22:374–7.

    Article  Google Scholar 

  33. Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD, Rehmar AJ. Radial optic neurotomy for central retinal vein occlusion. A retrospective pilot study of 11 consecutive cases (author’s reply). Retina. 2002;22:377–9.

    Article  Google Scholar 

  34. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology. 2001;108:2249–57.

    Article  PubMed  CAS  Google Scholar 

  35. Bynoe LA, Weiss JN. Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol. 2003;135:382–4.

    Article  PubMed  CAS  Google Scholar 

  36. Irvine WD, Johnson MW, Hernandez E, Olsen KR. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes. Arch Ophthalmol. 1991;109:718–22.

    Article  PubMed  CAS  Google Scholar 

  37. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers. 1999;30:427–34.

    PubMed  CAS  Google Scholar 

  38. Paques M, Vallée JN, Herbreteau D, Aymart A, Santiago PY, Campinchi-Tardy F, Payen D, Merlan JJ, Gaudric A, Massin P. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol. 2000;84:1387–91.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  39. Weinberg DV, Seddon JM, Albert DM, Jakobiec FA. Venous occlusive diseases of the retina. In: Albert & Jakobiec, Principles and practice of ophthalmology, Clinical practice, vol. 2. Philadelphia: W.B. Saunders Company; 1994. p. 735–46.

    Google Scholar 

  40. Staurenghi G, Lonati C, Aschero M, Orzalesi N. Arteriovenous crossing as a risk factor in branch retinal vein occlusion. Am J Ophthalmol. 1994;117:211–3.

    Article  PubMed  CAS  Google Scholar 

  41. Kumar B, Yu DY, Morgan WH, Barry CJ, Constable IJ, McAllister IL. The distribution of angioarchitectural changes within the vicinity of the arteriovenous crossing in branch retinal vein occlusion. Ophthalmology. 1998;105:424–7.

    Article  PubMed  CAS  Google Scholar 

  42. Osterloh MD, Charles S. Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol. 1988;106:1469–71.

    Article  PubMed  CAS  Google Scholar 

  43. Garcia-Arumi J, Martinez-Castillo V, Boixadera A, Blasco H, Corcostegui B. Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina. 2004;24:530–40.

    Article  PubMed  Google Scholar 

  44. Opremcak EM, Bruce RA. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy. A prospective review of 15 cases. Retina. 1999;19:1–5.

    Article  PubMed  CAS  Google Scholar 

  45. Mester U, Dillinger P. Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina. 2002;22:740–6.

    Article  PubMed  Google Scholar 

  46. Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: A report of 14 cases. Retina. 2004;24:348–55.

    Article  PubMed  Google Scholar 

  47. Cahill MT, Kaiser PK, Sears JE, Fekrat S. The effect of arteriovenous sheathotomy on cystoid macular edema secondary to branch retinal vein occlusion. Br J Ophthalmol. 2003;87:1329–32.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  48. Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E. Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina. 2007;27:49–54.

    Article  PubMed  Google Scholar 

  49. Han DP, Bennett SR, Williams DF, Dev S. Arteriovenous crossing dissection without separation of the retina vessels for treatment of branch retinal vein occlusion. Retina. 2003;23:145–51.

    Article  PubMed  Google Scholar 

  50. Chung EJ, Lee H, Koh HJ. Arteriovenous crossing sheathotomy versus intravitreal triamcinolone acetonide injection for treatment of macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2008;246:967–74.

    Article  PubMed  CAS  Google Scholar 

  51. Charbonnel J, Glacet-Bernard A, Korobelnik JF, Nyouma-Moune E, Pournaras CJ, Colin J, Coscas G, Soubrane G. Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol. 2004;242:223–8.

    Article  PubMed  Google Scholar 

  52. Genevois O, Paques M, Simonutti M, Sercombe R, Seylaz J, Gaudric A, Brouland JP, Sahel J, Vicaut E. Microvascular remodeling after occlusion-recanalization of a branch retinal vein in rats. Invest Ophthalmol Vis Sci. 2004;45:594–600.

    Article  PubMed  Google Scholar 

  53. Fujio N, Feke GT, Ogasawara H, Goger DG, Yoshida A, McMeel JW. Quantitative circulatory measurements in branch retinal vessel occlusion. Eye. 1994;8:324–8.

    Article  PubMed  Google Scholar 

  54. Yamaji H, Shiraga F, Tsuchida Y, Yamamoto Y, Ohtsuki H. Evaluation of arteriovenous crossing sheathotomy for branch retinal vein occlusion by fluorescein videoangiography and image analysis. Am J Ophthalmol. 2004;137:834–41.

    Article  PubMed  Google Scholar 

  55. Masaoka N, Nakaya K, Koura Y, Ohsaki M. Hemodynamic changes in two patients with retinal circulatory disturbances shown by fluorescein angiography using a scanning laser ophthalmoscope. Retina. 2001;21:155–60.

    Article  PubMed  CAS  Google Scholar 

  56. Branch vein occlusion study group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98:271–82.

    Google Scholar 

  57. Brown DM, Campochiaro PA, Bhisitkul RB, Ho AC, Gray S, Saroj N, Adamis AP, Rubio RG, Murahashi WY. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology. 2011;118:1594–602.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Hospital Vall d’Hebron, Paseo Vall Hebron, 119, Barcelona, 08035, Spain

    Jose Garcia-Arumi, Mahmoud Leila MD & Miguel Angel Zapata Victori

  2. Department of Ophthalmology, Rudolph Foundation Hospital, Vienna, Austria

    Susanne Binder MD

  3. The Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery, Vienna, Austria

    Susanne Binder MD

Authors
  1. Jose Garcia-Arumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susanne Binder MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahmoud Leila MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Miguel Angel Zapata Victori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jose Garcia-Arumi .

Editor information

Editors and Affiliations

  1. VMR Institute for Vitreous Macula Retina, Huntington Beach, California, USA

    J. Sebag

Electronic Supplementary Material

Video V.A.6-1

(MP4 131278 kb)

Video V.A.6-2

(MP4 131278 kb)

Video V.A.6-3

(MP4 131278 kb)

Video V.A.6-4

(MP4 131278 kb)

Video V.A.6-5

(MP4 131278 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Garcia-Arumi, J., Binder, S., Leila, M., Victori, M.A.Z. (2014). V.A.6. Vitreous Surgery of Arterial and Venous Retinovascular Diseases. In: Sebag, J. (eds) Vitreous. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1086-1_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1086-1_37

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1085-4

  • Online ISBN: 978-1-4939-1086-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation